Olympia Pharmaceuticals: what the FDA record shows
Olympia registered with the FDA in March 2014, which makes it one of the longest-registered outsourcing facilities on the list and one of the minority that has actually been inspected recently. The inspection produced a Form 483, which is the ordinary outcome rather than the exceptional one — of the 57 registered facilities that have been inspected at all, 55 were handed one.
Orlando, Florida.
What does the FDA record show for Olympia Pharmaceuticals?
Olympia Pharmaceuticals appears in the FDA's register of outsourcing facilities as Olympia Pharmaceuticals, Orlando, FL, registered since 2014-03-10. Its last inspection was 2025-08-08, and investigators left a Form 483, with the action based on that inspection recorded as open. No FDA warning letter was found under this name when the database was searched on 2026-08-28. The wider number is the one worth carrying away: of the 97 registered outsourcing facilities in the United States, 40 have never been inspected, and of the 57 that have, 55 were handed a Form 483 — only 2 came away without one. And whichever pharmacy fills your prescription, no seller on this site tells you which one it is.
The federal record
| Listed in the FDA register as | Olympia Pharmaceuticals, Orlando, FL |
|---|---|
| Initial registration | 2014-03-10 |
| Last inspection | 2025-08-08 |
| Form 483 issued | yes — read the 483 |
| Action based on last inspection | Open |
Read from the FDA register of outsourcing facilities on 2026-08-28. The FDA marks that page current as of 2026-08-25.
What was checked and not found
- No FDA warning letter is on record for Olympia Pharmaceuticals in the FDA's warning letter database, searched by company name on 28 August 2026.
- No recall is recorded against the facility in the FDA register.
Which seller uses Olympia Pharmaceuticals?
Nobody publishes it. 11 sellers were checked on the pages a buyer reads before ordering, last on 2026-08-26, and none names a compounding pharmacy at all. Since the pharmacy is what decides the quality of a compounded drug, that omission is the most consequential blank on a checkout page. The full disclosure audit lists what each seller was asked and what it said.
Questions
- Is Olympia Pharmaceuticals inspected by the FDA?
- Yes, because it is a registered outsourcing facility, which puts it on the FDA's inspection schedule and makes the outcome public. Its last inspection was 2025-08-08, and it produced a Form 483. That is more than can be said for most of the register: of the 97 facilities on it, 40 have never been inspected at all.
- Which telehealth company uses Olympia Pharmaceuticals?
- Unknown, and that is a finding rather than a research failure. 11 sellers were checked on the pages a buyer actually reads before ordering, last on 2026-08-26, and not one of them names a compounding pharmacy. The pharmacy decides the quality of a compounded drug, and it is the single fact the seller does not put on the page.
- Has Olympia Pharmaceuticals had an FDA warning letter?
- None found. The FDA's warning letter database was searched by company name on 2026-08-28 and returned nothing concerning this pharmacy. That is a statement about one database on one date, not a clean bill of health: a pharmacy the FDA does not inspect cannot accumulate federal findings either way.
- Is a Form 483 bad?
- On its own, barely informative. A 483 is the list of observations an investigator leaves at the end of an inspection, and almost every inspected outsourcing facility gets one — 55 of the 57 that have been inspected. What separates a routine 483 from a serious one is what happens next: whether the FDA escalates to a warning letter, a regulatory meeting or an untitled letter. For Olympia, the register records no such escalation.
Other pharmacies checked
- Empower Pharmacy — FDA registered, 3 warning letters
- Strive Pharmacy — not on the FDA register
- Hallandale Pharmacy — not on the FDA register
- Red Rock Pharmacy — not on the FDA register
- Belmar Pharmacy — not on the FDA register, 1 warning letter
Last updated 2026-08-28 — FDA register and warning letter database read